• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Topics » General Psychiatry

General Psychiatry
General Psychiatry RSS Feed RSS

Fact Sheet

Asenapine (Saphris, Secuado) Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Asenapine’s unique advantage is its availability in both sublingual and transdermal patch formulations, making it useful for patients who cannot or prefer not to swallow pills.


Read More
Fact Sheet

Nefazodone (Serzone) Fact Sheet [G]

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Nefazodone was once popular due to its low rate of sexual side effects, but its use has dramatically declined because of rare yet serious hepatic toxicity.


Read More
Fact Sheet

Topiramate (Eprontia, Qudexy XR, Topamax, Trokendi XR) Fact Sheet [G] for General Psychiatry

November 18, 2025

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.Full Fact Sheet Editorial Information

Topiramate is a reasonable off-label choice for alcohol use disorder and antipsychotic-induced weight gain.


Read More
Fact Sheet

Pregabalin (Lyrica, Lyrica CR) Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.Full Fact Sheet Editorial Information

Pregabalin is structurally related to gabapentin and is likely more effective for psychiatric disorders, especially generalized anxiety disorder (GAD) and social anxiety disorder. 


Read More
Fact Sheet

Atomoxetine (Strattera) Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Atomoxetine is a nonstimulant attention-deficit/hyperactivity disorder (ADHD) treatment that carries no abuse potential, causes less insomnia and anxiety, and is unlikely to worsen tics.



Read More
Fact Sheet

St. John’s Wort Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

St. John’s wort may be considered for short-term treatment of mild to moderate depression, especially in patients seeking natural options. However, its extensive drug interaction profile limits broader clinical use.


Read More
Fact Sheet

S-Adenosyl-L-Methionine (SAMe) Fact Sheet [G]

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.Full Fact Sheet Editorial Information

SAMe is a natural compound involved in neurotransmitter synthesis.


Read More
Fact Sheet

L-Methylfolate (Deplin) Fact Sheet [G]

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

L-methylfolate, the active form of folic acid, is required to synthesize neurotransmitters such as serotonin, dopamine, and norepinephrine.


Read More
Fact Sheet

Valproic Acid (Depakene, Depakote, others) Fact Sheet [G]

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.Full Fact Sheet Editorial Information

Valproic acid (VPA) is the go-to antimanic agent for acute manic episodes, featuring faster onset of response and a better adverse effect profile compared to lithium, fewer drug interactions than carbamazepine, and efficacy for rapid cycling and relapse prevention.


Read More
Fact Sheet

Oxcarbazepine (Oxtellar XR, Trileptal) Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.Full Fact Sheet Editorial Information

Previous 1 2 3 4 5 6 7 8 9 … 191 192 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • 3DCover_DTTD1e_sm3.png

    Difficult To Treat Depression: A Carlat Guide (2026)

    Effective tools for your most challenging cases.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2700377353.jpg
    General Psychiatry

    TMS, Teens, and Antidepressants

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.